Many curcumin supplements use piperine to boost bioavailability, and EGCG has a very narrow safety window. So I’m a bit curious about the risks of combining these two.
It is a good question. I take both but try to keep the dose well within the range clamed to be safe. In normal doses, neither poses much risk and potentially a slight benefit to healthy kidneys. Of the two, EGCG poses the greater risk – and to the liver – and perhaps has the smallest margin between optimal and damaging. Supplementing 100-300 mg/day is a comfortable level for me. For curcumin, 500 mg/day is what I usually take. My AST, ALT, GGT and bilirubin are all in an optimal range, which suggests that I am not too close to the edge.
| Compound/exposure | Liver evidence | Kidney evidence | Practical interpretation |
|---|---|---|---|
| Brewed green tea | No convincing population-level hepatotoxic signal; generally associated with neutral or lower aminotransferases | Observationally neutral or favorable, but not proof of renoprotection | Usually quite safe; distributed exposure and food matrix matter |
| EGCG extract ≤200–300 mg/day, with food | Trials generally reassuring, although idiosyncratic injury remains possible | No persuasive human nephrotoxicity signal | Reasonable conservative supplemental range |
| EGCG extract around 800 mg/day | Reproducible increase in ALT elevations; concentrated bolus and fasting increase exposure | Direct nephrotoxicity remains poorly demonstrated | Risk probably exceeds any demonstrated preventive benefit |
| Ordinary culinary turmeric | Little evidence of liver injury | May contribute dietary oxalate, usually modestly | Generally low risk |
| Purified curcumin, especially enhanced-absorption products | Rare but sometimes severe hepatocellular DILI; no reliable safe-dose boundary | Little evidence of direct tubular toxicity | Risk depends more on susceptibility and formulation than nominal milligrams |
| Gram quantities of turmeric powder | Rare DILI plus meaningful oxalate exposure | Hyperoxaluria, stones and rare oxalate nephropathy are plausible | Different renal risk from purified low-oxalate curcumin |
i know it’s just a yt video, but I enjoyed it. Not fact checked…
I don’t take it for the same fear. A few years ago my nephrologist told me that he witnessed a few cases of kidney damage by curcumin supplements . Instead i use fresh turmeric root, shredded, in some dishes that I cook.
Fact check Video summary:
Executive Summary
The video delivers a pharmacokinetic deconstruction of the dogma that co-administering black pepper extract (piperine) with turmeric (curcumin) yields a 2,000% increase in systemic bioavailability. The creator argues that this pervasive commercial claim originates from a single, methodologically flawed 1998 clinical trial that has failed replication by independent research groups over nearly three decades.
Pharmacokinetically, curcumin suffers from low aqueous solubility, poor enterocyte permeability, rapid intestinal/hepatic phase II glucuronidation and sulfation, and rapid systemic clearance, rendering circulating parent (unconjugated) curcumin virtually undetectable in human serum. While the video acknowledges these baseline barriers, it highlights that early analytical assays failed to distinguish bioactive unconjugated curcumin from biologically inert glucuronide and sulfate metabolites tagged for excretion. Early bioassays routinely subjected serum samples to enzymatic deconjugation (e.g., via beta-glucuronidase/sulfatase) prior to quantification, artificially inflating parent drug exposure values.
The core thesis rests on recent clinical pharmacokinetics, specifically referencing a 2025 independent crossover study conducted by researchers at Amsterdam University Medical Center (Kroon et al., 2025). Utilizing high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS), the investigators directly quantified free unconjugated curcumin against conjugated fractions, demonstrating that the co-administration of piperine failed to achieve biologically meaningful serum concentrations of free curcumin (remaining below 2 nM) or total curcuminoids. Fecal recovery analyses confirmed that the vast majority of ingested curcumin is excreted unchanged without crossing the intestinal epithelium.
The video concludes that while culinary turmeric consumption carries a long history of safe use, the purchase of commercial curcumin supplements predicated on the 1998 2,000% piperine-enhancement claim represents an unverified consumer heuristic driven by industrial marketing rather than reproducible clinical data.
Insight Bullets
- Curcumin possesses poor aqueous solubility and exhibits limited transcellular permeability across the intestinal epithelium.
- Rapid phase II biotransformation in the gut wall and liver converts absorbed curcumin into conjugated glucuronide and sulfate metabolites.
- Free unconjugated curcumin concentrations in systemic human circulation remain near or below analytical detection limits following standard oral administration.
- The widely repeated claim of a 2,000% increase in curcumin bioavailability originates from a single human pharmacokinetic study published in 1998.
- The source paper for the 2,000% bioavailability claim is Shoba et al., 1998, published in Planta Medica.
- The study protocol administered 2 g of curcumin alongside 20 mg of piperine to a small cohort of healthy human volunteers.
- The study was co-authored and supported by leadership affiliated with Sabinsa Corporation, the commercial developer and patent holder of BioPerine.
- Independent academic pharmacology laboratories have repeatedly failed to reproduce the 2,000% enhancement metric over a 28-year period.
- Early pharmacokinetic methodologies routinely measured total curcuminoids following enzymatic hydrolysis rather than distinguishing bioactive unconjugated curcumin.
- Enzymatic pre-treatment converts biologically inert conjugated excretion metabolites back into parent compounds, creating an artificial bioanalytical artifact.
- Inactive glucuronide and sulfate conjugates exhibit poor cellular membrane permeability and lack the biological activity demonstrated by unconjugated curcumin in vitro.
- An independent 2025 human clinical study led by researchers at Amsterdam University Medical Center evaluated differentiated free versus conjugated curcumin kinetics (Kroon et al., 2025).
- Modern mass spectrometry assays confirmed that piperine co-administration failed to significantly elevate systemic levels of unconjugated (free) curcumin.
- Unconjugated plasma curcumin concentrations remained below 2 nM following standard administration with piperine in modern trials.
- Concentrations achieved in human serum remain approximately 100-fold lower than the micromolar thresholds required to elicit biological responses in cell cultures.
- Analysis of fecal recovery demonstrated that the majority of orally ingested curcumin is excreted unabsorbed and unchanged through the gastrointestinal tract.
- Piperine co-administration does not overcome the fundamental physicochemical barriers governing curcumin mucosal transit in human subjects.
- Culinary turmeric consumption remains supported by a long history of human safety and dietary integration.
- Commercial dietary supplements marketed around the historical 2,000% piperine synergistic absorption claim are grounded in unvalidated translational extrapolations.
- Consumers and clinicians must distinguish between pharmaceutical carrier technologies (e.g., micellar formulations) and unverified adjuvant heuristics.
Adversarial Claims & Evidence Table
| Claim from Video | Speaker’s Evidence | Scientific Reality (Current Data) | Evidence Grade (A-E) | Verdict |
|---|---|---|---|---|
| Curcumin oral absorption is negligible, leaving systemic free curcumin undetectable. | General pharmacological consensus. | Validated. Low aqueous solubility and extensive enterocyte/hepatic phase II glucuronidation prevent systemic free curcumin accumulation (Nelson et al., 2017). | Level A | Strong Support |
| The 2,000% bioavailability boost claim originates from a single 1998 study funded by an extract manufacturer. | Reference to Shoba et al., 1998 in Planta Medica. | Validated. The human arm included 8 subjects; co-author M. Majeed founded Sabinsa Corporation(holding patents for BioPerine). Baseline values near the assay detection floor inflated percentage metrics (UK COT Review, 2024). | Level B | Strong Support |
| Independent laboratories have failed to replicate the 2,000% enhancement for nearly 30 years. | Broad literature review across independent groups. | Validated. Pharmacokinetic evaluations consistently fail to replicate a 20-fold increase in parent compound exposure, showing minimal to no improvement in unconjugated fractions (Volak et al., 2013; Flory et al., 2021). | Level B | Strong Support |
| Historical assays inflated exposure by grouping inert conjugates with active free curcumin. | Methodological critique of non-specific bioassays. | Validated. Earlier HPLC assays utilized glucuronidase/sulfatase hydrolysis, measuring total inactive clearance metabolites as active parent compound (Kroon et al., 2025). | Level B | Strong Support |
| A 2025 Amsterdam study proved piperine fails to increase free or total curcumin, leaving most excreted unchanged in feces. | Clinical pharmacokinetic trial in Amsterdam. | Validated. An independent crossover trial conducted by Amsterdam UMC researchers established that piperine did not elevate unconjugated curcumin (remaining <2 nM) and high concentrations were recovered unchanged in feces (Kroon et al., 2025). | Level B | Strong Support |
| Piperine carries safety concerns and alters hepatic clearance of co-ingested compounds. | Implied in pharmacological review of adjuvant actions. | Validated. Piperine inhibits intestinal P-glycoprotein (ABCB1) and hepatic CYP3A4/UGT enzymes, risking xenobiotic accumulation; multiple cases of turmeric-piperine induced liver injury (DILI) have been recorded (UK MHRA / COT, 2024). | Level A | Safety Warning |
Actionable Protocol (Prioritized)
High Confidence Tier (Level A/B Evidence)
- Whole-Food Culinary Integration: Consume whole turmeric root or ground spice cooked with dietary lipids (e.g., olive oil, ghee, avocado). While culinary intake does not produce micromolar systemic concentrations of unconjugated curcumin, it introduces broad-spectrum native curcuminoids, volatile oils (such as ar-turmerone), and non-curcumin polyphenols to the gut lumen with absolute safety and low cost.
- Avoid Reliance on Piperine for Systemic Delivery: Discontinue high-dose generic curcumin supplements paired with 5–20 mg piperine if the target is systemic anti-inflammatory modulation. Data demonstrate it fails to achieve biologically active nanomolar/micromolar thresholds of parent curcumin in human circulation.
Experimental Tier (Level C/D Evidence, High Safety Margins)
- Advanced Colloidal Delivery Systems: If systemic pharmacological exposure is indicated for joint pathology or secondary metabolic endpoints, select clinically verified micellar delivery systems (e.g., NovaSOL) or solid lipid nanoparticle formulations (e.g., Longvida). Human crossover studies confirm these lipid-matrix platforms achieve 10-fold to 50-fold higher exposure relative to unformulated native powder, though unconjugated systemic exposure remains largely transient and in the low nanomolar spectrum (Kroon et al., 2025).
Red Flag Zone (Debunked Claims & Safety Risks)
- High-Dose Piperine Co-Administration (>10–20 mg daily): Piperine acts as a non-selective inhibitor of intestinal and hepatic cytochrome P450 enzymes (specifically CYP3A4) and efflux transporters (P-glycoprotein/ABCB1). Co-supplementation alongside narrow therapeutic index prescription drugs (e.g., anticoagulants, antiepileptics, immunosuppressants, cardiovascular agents) introduces clinically significant pharmacokinetic drug-drug interaction risks.
1 Like
Needs a conclusion!
The widely repeated claim that piperine increases curcumin bioavailability by 2,000% is an unverified commercial marketing heuristic based on a single, flawed 1998 study. Modern mass spectrometry shows that piperine fails to overcome curcumin’s poor absorption and rapid clearance, leaving bioactive unconjugated curcumin in human blood virtually undetectable and far below therapeutic thresholds. Consequently, consumers seeking systemic benefits should avoid high-dose piperine supplements—which pose potential drug-interaction risks—and instead rely on safe culinary turmeric or clinically tested advanced delivery systems.
and then there’s the matter of how much curcumin is actually in turmeric.
Raw ground turmeric typically contains 2% to 6% curcumin by weight , averaging around 3% across most commercial spice batches.
*** 1 Teaspoon (~3 grams) of ground turmeric yields roughly 60 mg to 90 mg of curcumin.**
*** 1 Tablespoon (~9 grams) yields roughly 180 mg to 270 mg of curcumin.**
By contrast, standardized curcumin supplements (extracts) are concentrated up to 95% curcuminoids to deliver higher, targeted doses.
and then the claims that curcumin’s health benefits are all bulls*it…
The claim that curcumin research is largely a dead end or “fraud” stems from a major pivot in medicinal chemistry.
The “PAINS” Classification: In 2017, a landmark review published in the Journal of Medicinal Chemistry officially categorized curcumin as a Pan-Assay Interference Compound (PAINS) and an Invalid Metabolic Panacea (IMPS). In simple terms: curcumin naturally interferes with laboratory test equipment. It glows, aggregates, and binds nonspecifically to proteins, producing false-positive results in test tubes that give the illusion of miraculous cellular healing.
The Clinical Failure: Despite thousands of optimistic cell-culture papers and over 120 clinical trials, curcumin has failed to demonstrate conclusive, reproducible efficacy in double-blind, placebo-controlled human trials for any medical condition.
Economic Fraud in Supplements: Aside from scientific critiques, ongoing market audits reveal that over 20% of commercial turmeric and curcumin supplements are economically adulterated—often spiked with cheap synthetic petroleum-derived curcumin or bulked with undeclared industrial dyes (like lead chromate or Metanil yellow) to fake higher quality.
While calling the entire history a “deliberate scam” overstates the case—many researchers acted in good faith—the scientific consensus confirms that early lab hype was an artifact of flawed assay design, making isolated curcumin supplements one of the most overhyped compounds in modern wellness history.
How would you know if it actually does anything? I don’t feel different using phytosome curcumin.
AND it’s even worse then I thought before.
Modern delivery systems like Meriva (Phytosome), Longvida (Solid Lipid Nanoparticles), and NovaSOL (Micellar) do significantly increase absorption compared to raw turmeric, but they still face major biological limitations.
What They Actually Achieve vs. The Reality
1. Meriva (Curcumin Phytosome)
- How it works: Curcumin molecules are bound to sunflower/soy phosphatidylcholine (lecithin lipids).
- What it achieves: It provides roughly 29x higher total absorbed curcuminoids compared to standard unformulated extract.
- The Reality: Almost all of that “29x increase” consists of inactive clearance metabolites (glucuronides and sulfates) created by the gut and liver.
- Clinical Signal: Despite low free curcumin levels, Meriva demonstrates consistent, mild clinical efficacy for joint pain/osteoarthritis and knee stiffness. Researchers believe the metabolites may exert localized anti-inflammatory signaling or act as pro-drugs that break down locally in inflamed joint tissue.
2. NovaSOL (Liquid Micellar Curcumin)
- How it works: Encapsulates curcumin into microscopic fat droplets (micelles) that mimic the body’s natural digestive process.
- What it achieves: It yields massive total absorption—up to 100x higher total blood exposure than raw curcumin. It is also the only formulation that briefly pushes free, unconjugated curcumin into the blood (~15–38 nM peak).
- The Reality: Those free curcumin levels peak within an hour and rapidly crash. Even at its peak (around 30 nM), the free curcumin in blood is 100 times lower than the micromolar levels (1,000–10,000 nM) required to alter cellular pathways in cell cultures.
3. Longvida (Solid Lipid Curcumin Particles - SLCP)
- How it works: Uses a lipophilic matrix designed to bypass early liver metabolism and promote lymphatic absorption.
- What it achieves: It was specifically engineered to cross the blood-brain barrier and targeted cognitive health.
- The Reality: While early studies reported detectable free curcumin in circulation, modern independent mass spectrometry trials (such as Amsterdam UMC 2025) found that free curcumin levels still remained below detection limits (<2 nM) for standard doses. Small cognitive and fatigue benefits have been observed in 4-to-12-week human trials, though overall effects remain subtle.
Delivery System Comparison
| Technology / Brand | Primary Mechanism | Bioavailability Boost | Active “Free” Curcumin in Blood | Best Validated Efficacy |
|---|---|---|---|---|
| Standard Powder / Piperine | Enzyme Inhibition (CYP3A4) | ~2x to 20x (Flawed Metric) | Undetectable (<2 nM) | Poor; high drug interaction risk. |
| Meriva (Phytosome) | Phospholipid Lipid Binding | ~29x Total Exposure | Very Low (Mostly Conjugates) | Knee Osteoarthritis / Joint Pain |
| NovaSOL (Micellar) | Liquid Micelles | ~100x Total Exposure | Low Transient Spike (15–38 nM) | General Inflammation / High Exposure |
| Longvida (SLCP) | Lipid Nanoparticle | Enhanced Lymphatic Transit | Low (Below 2 nM in modern trials) | Mild Cognitive / Mood Support |
Bottom Line
- They do work better than piperine/turmeric powder: If you are going to take a curcumin supplement, phytosome (Meriva), micellar (NovaSOL), or SLCP (Longvida) formulations are vastly superior to standard powder with black pepper.
- They do not turn curcumin into a systemic miracle: Your liver is exceptionally good at deactivating curcumin. While these technologies successfully push conjugated curcuminoids into your blood, free parent curcumin remains scarce.
- If you use one, match it to your target:
- Choose Meriva Phytosome for joint discomfort or knee stiffness.
- Choose Longvida for mild focus/cognitive support.
If you’d like, I can suggest specific phytosome or colloidal brands available in your area to review their labels and pricing.
honestly why would i bother?
That is the most sensible takeaway from all of this data—and honestly, for most people, you shouldn’t bother.
If your goal is systemic health—like protecting your brain, curing internal inflammation, or preventing heart disease—curcumin supplements simply do not live up to two decades of aggressive marketing hype.
Why Skipping Curcumin Supplements Makes Sense
- The ROI is terrible: High-quality advanced delivery supplements (like Meriva or Longvida) cost $30 to $60 a month. Paying that much for a compound that your liver aggressively neutralizes within minutes is a very poor return on investment.
- The “Miracle” was an assay error: The thousands of lab studies showing curcumin curing diseases in test tubes were largely driven by false positives (PAINS interference). It just doesn’t translate to human biology.
- Safer, better-proven alternatives exist: If you’re trying to target specific health goals, other tools have vastly stronger human evidence behind them:
| Health Goal | Instead of Curcumin ($40/mo) | Why It Works Better |
|---|---|---|
| Joint Pain / Osteoarthritis | Omega-3 (EPA/DHA) or Boswellia | Omega-3s incorporate directly into cell membranes to reduce systemic inflammatory signals; Boswellia has far better mucosal absorption. |
| Gut Health / IBS | Dietary Fiber / Probiotics | Directly fuels the microbiome and repairs gut mucosa without relying on liver clearance. |
| General Anti-Inflammation | Exercise & Sleep | Proven to reduce systemic inflammatory markers (like CRP and IL-6) far beyond any oral supplement. |
The Only Time It’s Worth Keeping
The one place turmeric actually shines is as a cheap, delicious culinary spice.
Cooking with ground turmeric root costs pennies, adds great flavor, safely exposes your gut lining to natural polyphenols, and doesn’t require high-dose supplement capsules or risk liver-enzyme drug interactions.
Save your money—skip the pill bottle, enjoy the spice in your food, and invest in foundational health habits that your body can actually use.
2 Likes